AI for Increasing Reporting of Fatty Liver to Promote Early Detection

Nanox.AI’s unique and pioneering algorithm highlights liver density measurements using abdominal and chest CTs. Low liver density is suggestive of fatty liver disease.

Discover the Need for
Advanced Liver Care

The global prevalence of MASLD
The global prevalence of MASLD is 25%
and it is considered a “silent” global pandemic
Prolonged high fat levels in t
Prolonged high fat levels in the liver can lead to fibrosis or MASH,
which can progress to cirrhosis. The mortality rate is 7.9% within seven years.
Early detection of liver di
Early detection of liver disease can help improve patient outcomes
and reduce its complications and healthcare costs
MASLD is associated with annua
MASLD is associated with annual direct medical costs of ~$103 billion 
$1613 per patient

Proven Value

In a study published in AJR, the Nanox.AI liver solution demonstrated enhanced diagnostic accuracy and automation efficiency

In a study published in AJR, t

FLD and Cardiovascular Risk 

There is a strong association between NAFLD and atherosclerotic heart disease, heart failure, and arrhythmias, particularly atrial fibrillation

FLD and Cardiovascular Risk

Want to Learn More?

Get Your Demo

AI Solutions for Better Outcomes 

Improving Clinical Outcome

Improving Clinical Outcome

The AI-driven analysis enhances clinical outcomes by automatically measuring liver attenuation on contrast and non-contrast chest and abdominal CT scans.

Generating Value

Generating Value

Nanox.AI measures liver attenuation (HU), highlights results that fall outside the reference range, and visualizes the measurement location.

Seamless Integration

Seamless Integration

Seamless integration with existing Picture Archiving and Communication Systems (PACS) enables timely and appropriate preventive care.

Adding Clinical Value to Radiology Reports

The AI Liver solution helps bridge the divide between radiology and gastroenterology, two medical specialties that often use different terms and descriptions to assess imaging data by adding clinical value as numerical scoring to the radiology report

Do More With AI

Join us on Nanox.AI’s journey to discover how our innovative technology can elevate your practice and drive healthcare standards to new heights.

Exploring Insights and Innovations

Explore leading articles in the field of medical imaging, featuring cutting-edge research, breakthrough technologies, and in-depth analyses of the future of medicine. Read more and stay updated with the latest knowledge and development.

Artículo
Hígado graso

Guía práctica de la AASLD sobre la evaluación clínica y el tratamiento de la enfermedad del hígado graso no alcohólico

Este nuevo documento de orientación de la AASLD refleja muchos avances en el campo que son pertinentes para cualquier profesional que atienda a pacientes con EHGNA y enfatiza los avances en la estratificación de riesgos no invasivos y las terapias.

Seguir leyendo Clock 15 Tiempo de lectura
Artículo
Hígado graso

Detección de esteatosis hepática moderada en la tomografía computarizada con contraste de fase venosa portal: evaluación mediante una herramienta de inteligencia artificial automatizada

La tomografía computarizada pre-contraste es un método establecido para evaluar la esteatosis hepática; la tomografía computarizada post-contraste históricamente ha tenido limitaciones para este propósito.

Seguir leyendo Clock 10 Tiempo de lectura
Artículo
Hígado graso

Enfermedad del hígado graso no alcohólico, insuficiencia cardíaca y mortalidad a largo plazo: Perspectivas de la Encuesta Nacional de Examen de Salud y Nutrición

Evaluar la asociación entre la enfermedad del hígado graso no alcohólico (EHGNA), la insuficiencia cardíaca (IC) y la mortalidad por todas las causas. Tanto la EHGNA como la IC están aumentando en prevalencia debido a factores de riesgo compartidos.

Seguir leyendo
Explore More
Únase a la vanguardia de la tecnología
Contáctenos

Su información será manejada como se detalla en nuestra política de privacidad